Aethlon Medical Enters Into Materials Transfer Agreement for

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...

Related Keywords

Switzerland , London , City Of , United Kingdom , Zurich , Züsz , Swiss , James Frakes , Susan Noonan , Santersu Nucleocapture , Aethlon Hemopurifier , Scott Maguire , Jim Frakes , Securities Exchange , Nasdaq , Exchange Commission , Company Contact , Aethlon Medical Inc , Sa Noonan Communications , Drug Administration , Prnewswire Aethlon Medical Inc , Company Annual Report On Form , Us Food Drug Administration , Aethlon Medical Will Perform Pre Clinical Studies , Explore Potential Synergies With , Blood Filtration , Materials Transfer Agreement , Neutrophil Extracellular Traps , Interim Chief Executive Officer , Chief Financial Officer , Breakthrough Device , Investigational Device Exemption , Securities Act , Securities Exchange Act , Annual Report , Chief Executive Officer , Chief Financial , Aethlon Medical , Nc , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment , Biotechnology , Clinical Trials Amp Medical Discoveries , Contracts ,